NEW YORK ( TheStreet) -- Jones Soda (JSDA) was one of several stocks trading near $5 poised to move on above-average volume Thursday, as shares rallied more than 60% after announcing a distribution deal with the world's largest retailer.
Jones Soda announced a deal Thursday with Wal-Mart (WMT - Get Report) that authorizes the soda maker to retail its products in Wal-Mart's approximately 3,800 U.S.-based stores. The deal increases Jones' total retail outlet distribution by nearly 10%, the company said.
Shares of Jones Soda jumped by 42 cents, or 61.8, to $1.10 in the premarket session. The 50-day average daily volume for Jones Soda is 496,000, according to the Nasdaq.
FSI International (FSII) jumped by 50 cents, or 18.2%, to $3.25 in the premarket session after the semiconductor equipment company raised its third-quarter revenue guidance to a range of $27 million to $29 million, from the prior range of $23 million to $25 million.Assuming it can achieve anticipated gross profit margin and the operating expense levels, FSI International said it expects third-quarter net income of $5 million to $6 million, up from its prior guidance range of $2.5 million to $3 million. The 50-day average daily volume for FSI International is 577,000. Elsewhere, Jamba (JMBA - Get Report) slid by 14 cents, or 5.3%, to $2.50 in the premarket session after the company posted a first-quarter loss of 13 cents a share on revenue of $80.43 million, which came in below the two-analyst average estimate for a loss of 7 cents a share on revenue of $81.58 million. The 50-day average daily volume for Jamba is 1.39 million. Alexza Pharmaceuticals (ALXA - Get Report) climbed by 18 cents, or 6%, to $3.20 in the premarket session after the company said clinical study results show its Staccato Loxapine (AZ-004) reduced signs and symptoms of agitation as early as ten minutes after dosing in patients with schizophrenia or bipolar disorder. In addition, Alexza Pharmaceuticals said that it has secured a $25 million committed equity financing facility with Azimuth Opportunity. The 50-day average daily volume for Alexza Pharmaceuticals is 165,000. Beacon Power (BCON) rallied by 4 cents, or 11.1%, to 40 cents in the premarket session after Ardour Capital initiated coverage of the company with a buy rating and a $1.50 price target. The firm cited Beacon Power's significant growth prospects thanks to a future build out of its merchant frequency regulation plants. The 50-day average daily volume for Beacon Power is 1.08 million. Sirius XM (SIRI - Get Report) rebounded by 10 cents, or 12%, to 98 cents in the premarket session in the absence of any company-specific news. On Wednesday, Sirius XM shares fell more than 11% to 88 cents, the stock's second consecutive close below the $1 mark. The 50-day average daily volume for Sirius XM is 137 million.
|More on Sirius XM Sirius XM: 3 Biggest Risks|